“2) Using … in the lentinan … tegafur for gastric cancer, clearly showing such high survival rates as 12.97% (P less than 0.05) at two years after, and … four years after respectively, and for colorectal cancer, 9.10% and 4.55% at two years and three years after, respectively.”